Cardiovascular Disease and Rheumatoid Arthritis: An Update

Proteomic profiling following immunoaffinity capture of high-density lipoprotein: Association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis

(2012) Junji Watanabe et al.   ARTHRITIS AND RHEUMATISM

Lipid Testing in Patients with Rheumatoid Arthritis and Key Cardiovascular-Related Comorbidities: A Medicare Analysis

(2012) Christie M. Bartels et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Prevalence of Traditional Modifiable Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis: Comparison with Control Subjects from the Multi-Ethnic Study of Atherosclerosis

(2012) Cecilia P. Chung et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study

(2012) Jon T Giles et al.   ARTHRITIS RESEARCH & THERAPY

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study

(2011) M. A. De Vera et al.   ANNALS OF THE RHEUMATIC DISEASES

Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study

(2011) A M van Sijl et al.   ANNALS OF THE RHEUMATIC DISEASES

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

(2011) E. Myasoedova et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

(2011) Lotta Ljung et al.   ARTHRITIS AND RHEUMATISM

Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis

(2011) Matthew R. Evans et al.   ARTHRITIS AND RHEUMATISM

Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor α-induced VE-cadherin cleavage

(2011) Adama Sidibé et al.   ARTHRITIS AND RHEUMATISM

Is Small Artery Elasticity Decreased Prior to Intima-Media Thickening in Patients with Longstanding Rheumatoid Arthritis?

(2011) HELMY J. HINKEMA et al.   JOURNAL OF RHEUMATOLOGY

Tocilizumab Monotherapy Reduces Arterial Stiffness as Effectively as Etanercept or Adalimumab Monotherapy in Rheumatoid Arthritis: An Open-label Randomized Controlled Trial

(2011) KENSUKE KUME et al.   JOURNAL OF RHEUMATOLOGY

Effectiveness of Statins on Total Cholesterol and Cardiovascular Disease and All-cause Mortality in Osteoarthritis and Rheumatoid Arthritis

(2011) X. SHENG et al.   JOURNAL OF RHEUMATOLOGY

Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update

(2011) Lori Mosca et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study

(2011) Lena Innala et al.   ARTHRITIS RESEARCH & THERAPY

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

(2010) J. D. Greenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study

(2010) A. Jamnitski et al.   ANNALS OF THE RHEUMATIC DISEASES

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

(2010) A. Ogata et al.   ANNALS OF THE RHEUMATIC DISEASES

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

(2010) A. G. Semb et al.   ANNALS OF THE RHEUMATIC DISEASES

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

(2010) N. B. Klarenbeek et al.   ANNALS OF THE RHEUMATIC DISEASES

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

(2010) Mark Lunt et al.   ARTHRITIS AND RHEUMATISM

Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors

(2010) Tracey E. Toms et al.   Current Vascular Pharmacology

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

(2010)   LANCET

Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions

(2010) Norihiro Nishimoto et al.   Modern Rheumatology

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

(2010) Olaf Schultz et al.   PLoS One

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

(2010) S. L. Westlake et al.   RHEUMATOLOGY

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

(2010) Anne G. Semb et al.   RHEUMATOLOGY

Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis

(2010) Ziyad Al-Aly et al.   Translational Research

Systematic review and meta-analysis: Anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

(2010) Cheryl Barnabe et al.   ARTHRITIS CARE & RESEARCH

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

(2009) T. E. Toms et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

(2009) Christina Charles-Schoeman et al.   ARTHRITIS AND RHEUMATISM

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus

(2009) Maureen McMahon et al.   ARTHRITIS AND RHEUMATISM

Inflammation Impairs Reverse Cholesterol Transport In Vivo

(2009) Fiona C. McGillicuddy et al.   CIRCULATION

Tumor Necrosis Factor-α Antagonists Improve Aortic Stiffness in Patients With Inflammatory Arthropathies

(2009) Kristin Angel et al.   HYPERTENSION

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis

(2008) Carlos Gonzalez-Juanatey et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Lipid Profiles in Patients with Rheumatoid Arthritis: Mechanisms and the Impact of Treatment

(2008) George Steiner et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

(2007) A Gonzalez et al.   ANNALS OF THE RHEUMATIC DISEASES